Mineralys Therapeutics Cash Flow Statement 2020-2025 | MLYS

Fifteen years of historical annual cash flow statements for Mineralys Therapeutics (MLYS).

Annual Data | Millions of US $ except per share data

Metric Name
Net Income/Loss
Total Depreciation And Amortization - Cash Flow
Other Non-Cash Items
Total Non-Cash Items
Change In Accounts Receivable
Change In Inventories
Change In Accounts Payable
Change In Assets/Liabilities
Total Change In Assets/Liabilities
Cash Flow From Operating Activities
Net Change In Property, Plant, And Equipment
Net Change In Intangible Assets
Net Acquisitions/Divestitures
Net Change In Short-term Investments
Net Change In Long-Term Investments
Net Change In Investments - Total
Investing Activities - Other
Cash Flow From Investing Activities
Net Long-Term Debt
Net Current Debt
Debt Issuance/Retirement Net - Total
Net Common Equity Issued/Repurchased
Net Total Equity Issued/Repurchased
Total Common And Preferred Stock Dividends Paid
Financial Activities - Other
Cash Flow From Financial Activities
Net Cash Flow
Stock-Based Compensation
Common Stock Dividends Paid
20242023202220212020
$-177.81$-71.90$-29.80$-19.41$-3.43
$0.04$0$0$0$0
$1.93$-1.81$-0.19$0.76$0.48
$1.97$-1.81$-0.19$0.76$0.48
$0.42$-0.36$0$0$0
$0$0$0$0$0
$0$0$0$0$0
$4.94$-9.53$-2.24$-0.39$-0.06
$9.52$-7.47$0.77$4.09$0.48
$-166.31$-81.17$-29.22$-14.56$-2.46
$-0.10$0$0$0$0
$0$0$0$0$0
$0$0$0$0$0
$115$-160.47$-21.76$0$0
$0$0$0$0$0
$115$-160.47$-21.76$0$0
$0$0$0$0$0
$115$-160.47$-21.76$0$0
$0$0$0$0$0
$0$0$0$0$3.85
$0$0$0$0$3.85
$116$203$-1.63$0$0
$116$203$128$23.81$-0.02
$0$0$0$0$0
$-0.21$0.06$0$0$0
$116$203$128$23.81$3.83
$64.79$-38.40$77.04$9.25$1.37
$11.34$5.06$0.46$0.08$0.00
$0$0$0$0$0